Karyopharm Therapeutics reported $66.98M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US USD 8.76B 123M
Abbvie ABBV:US USD 10.21B 1.08B
Amgen AMGN:US USD 4.61B 695M
AstraZeneca AZN:LN USD 9.74B 495M
Astrazeneca AZN:US USD 9.74B 495M
Avrobio Inc AVRO:US USD 22.98M 4.79M
Biocryst Pharmaceuticals BCRX:US USD 93.27M 6.98M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Eli Lilly And LLY:US USD 5.47B 200.3M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Karyopharm Therapeutics KPTI:US USD 66.98M 15.6M
Macrogenics MGNX:US USD 66.69M 1.13M
Merk MRK:US USD 10.32B 624M
Mirati Therapeutics MRTX:US USD 191.87M 9.31M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Novartis NOVN:VX USD 11.05B 378M
Novartis NVS:US USD 11.05B 378M
Pfizer PFE:US USD 19.12B 5.9B
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Roche Holding ROG:VX 20.75B 3.26B
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Takeda 4502:JP JPY 949.56B 51.69B
Tg Therapeutics TGTX:US USD 35.06M 4.48M
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
Xencor XNCR:US USD 65.65M 7.47M